Jonathan B.

Jonathan B. is a seasoned professional in corporate development and business strategy, currently serving as the Senior Director of Corporate Development at Ascidian Therapeutics since December 2023. Previous roles include positions in corporate development at Replicate Bioscience, Inc. and as a Business Development professional at ATP (Apple Tree Partners). Jonathan's experience also spans a directorial role in BD&L Finance at Novartis Institutes for BioMedical Research and a directorial position in Corporate Strategy focusing on Portfolio Analytics at Acceleron Pharma, which was acquired by Merck. Prior to these roles, Jonathan spent over a decade at PwC, advancing from Associate to Director within the Deals and Valuation Group. Jonathan holds a BA in Economics from Brandeis University and an MA in International Economics and Finance from the Brandeis School of Business and Economics, complemented by education at Copenhagen Business School.